Viewing Study NCT04574934


Ignite Creation Date: 2025-12-25 @ 2:34 AM
Ignite Modification Date: 2025-12-30 @ 7:20 AM
Study NCT ID: NCT04574934
Status: UNKNOWN
Last Update Posted: 2020-10-05
First Post: 2020-08-05
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Effect of Aquatic Therapy on Pulmonary Functions in Patients With Muscular Dystrophy
Sponsor: South Valley University
Organization:

Study Overview

Official Title: Effect of Aquatic Therapy on Pulmonary Functions in Patients With Muscular Dystrophy
Status: UNKNOWN
Status Verified Date: 2020-09
Last Known Status: ACTIVE_NOT_RECRUITING
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: This study aimed to assess the efficacy of aquatic therapy on pulmonary functions in patients with muscular dystrophy.
Detailed Description: Muscular dystrophy (MD) is a group of muscle diseases that results in increasing weakening and breakdown of skeletal muscles over time. The disorders differ in which muscles are primarily affected, the degree of weakness, how fast they worsen, and when symptoms begin. Many people will eventually become unable to walk. Some types are also associated with problems in other organs. The muscular dystrophy group contains thirty different genetic disorders that are usually classified into nine main categories or types.

The signs and symptoms consistent with muscular dystrophy are: progressive muscular wasting, poor balance, scoliosis (curvature of the spine and the back), progressive inability to walk, waddling gait, Calf deformation, Limited range of movement,respiratory difficulty, cardiomyopathy and muscle spasms

Study Oversight

Has Oversight DMC: False
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: